Garrelts A - Search Results

1

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.

Warren RB, See K, Burge R, Zhang Y, Brnabic A, Gallo G, Garrelts A, Egeberg A. Warren RB, et al. Among authors: garrelts a. Dermatol Ther (Heidelb). 2020 Feb;10(1):73-86. doi: 10.1007/s13555-019-00337-y. Epub 2019 Nov 4. Dermatol Ther (Heidelb). 2020. PMID: 31686337 Free PMC article.

2

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.

Egeberg A, See K, Garrelts A, Burge R. Egeberg A, et al. Among authors: garrelts a. BMC Dermatol. 2020 May 20;20(1):3. doi: 10.1186/s12895-020-00099-7. BMC Dermatol. 2020. PMID: 32434510 Free PMC article.

3

Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial.

Blauvelt A, Lebwohl MG, Mabuchi T, Leung A, Garrelts A, Crane H, ElMaraghy H, Patel H, Ridenour T, See K, Gallo G, Paul C. Blauvelt A, et al. Among authors: garrelts a. J Am Acad Dermatol. 2021 Aug;85(2):360-368. doi: 10.1016/j.jaad.2020.11.022. Epub 2020 Nov 28. J Am Acad Dermatol. 2021. PMID: 33253833 Free article. Clinical Trial.

4

Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis.

Blauvelt A, Gooderham M, Griffiths CEM, Armstrong AW, Zhu B, Burge R, Gallo G, Guo J, Garrelts A, Lebwohl M. Blauvelt A, et al. Among authors: garrelts a. Dermatol Ther (Heidelb). 2022 Mar;12(3):727-740. doi: 10.1007/s13555-022-00690-5. Epub 2022 Feb 23. Dermatol Ther (Heidelb). 2022. PMID: 35195887 Free PMC article.

5

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis.

Leonardi CL, See K, Burge R, Sun Z, Zhang Y, Mallbris L, Garrelts A, Warren RB. Leonardi CL, et al. Among authors: garrelts a. Adv Ther. 2022 May;39(5):2256-2269. doi: 10.1007/s12325-022-02065-w. Epub 2022 Mar 22. Adv Ther. 2022. PMID: 35316500 Free PMC article.

6

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.

Paller AS, Seyger MMB, Magariños GA, Pinter A, Cather JC, Rodriguez-Capriles C, Zhu D, Somani N, Garrelts A, Papp KA; IXORA-PEDS Investigators. Paller AS, et al. Among authors: garrelts a. JAMA Dermatol. 2022 May 1;158(5):533-541. doi: 10.1001/jamadermatol.2022.0655. JAMA Dermatol. 2022. PMID: 35416908 Free PMC article. Clinical Trial.

7

Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA.

Blauvelt A, Garrelts A, Malatestinic W, Birt J, Zhu B, Feely M. Blauvelt A, et al. Among authors: garrelts a. Dermatol Ther (Heidelb). 2023 Nov;13(11):2911-2916. doi: 10.1007/s13555-023-01015-w. Epub 2023 Sep 26. Dermatol Ther (Heidelb). 2023. PMID: 37752409 Free PMC article. No abstract available.

8

Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.

Egeberg A, Kristensen LE, Puig L, Rich P, Smith SD, Garrelts A, See K, Holzkaemper T, Fotiou K, Schuster C. Egeberg A, et al. Among authors: garrelts a. J Dermatolog Treat. 2023 Dec;34(1):2263108. doi: 10.1080/09546634.2023.2263108. Epub 2023 Oct 2. J Dermatolog Treat. 2023. PMID: 37781881 Free article.

9

Basic Considerations for the Use of Monoclonal Antibodies in Migraine.

Levin M, Silberstein SD, Gilbert R, Lucas S, Munsie L, Garrelts A, Kennedy K, Everman N, Pearlman E. Levin M, et al. Among authors: garrelts a. Headache. 2018 Nov;58(10):1689-1696. doi: 10.1111/head.13439. Epub 2018 Nov 13. Headache. 2018. PMID: 30426478 Free PMC article. Review.

10

Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO).

Pinter A, Eyerich K, Costanzo A, Garrelts A, Schuster C, Mert C, Lampropoulou A, Fotiou K, Maul JT, Papp KA. Pinter A, et al. Among authors: garrelts a. J Dermatolog Treat. 2024 Dec;35(1):2350227. doi: 10.1080/09546634.2024.2350227. Epub 2024 May 26. J Dermatolog Treat. 2024. PMID: 38797734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page